Xiaopin Duan

5.8k total citations · 4 hit papers
44 papers, 5.0k citations indexed

About

Xiaopin Duan is a scholar working on Biomedical Engineering, Molecular Biology and Oncology. According to data from OpenAlex, Xiaopin Duan has authored 44 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Biomedical Engineering, 15 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Xiaopin Duan's work include Nanoplatforms for cancer theranostics (23 papers), Nanoparticle-Based Drug Delivery (11 papers) and RNA Interference and Gene Delivery (8 papers). Xiaopin Duan is often cited by papers focused on Nanoplatforms for cancer theranostics (23 papers), Nanoparticle-Based Drug Delivery (11 papers) and RNA Interference and Gene Delivery (8 papers). Xiaopin Duan collaborates with scholars based in China, United States and Singapore. Xiaopin Duan's co-authors include Wenbin Lin, Christina Chan, Yaping Li, Nining Guo, Ralph R. Weichselbaum, Chunbai He, Wenbo Han, Christopher Poon, Jisheng Xiao and Shirui Mao and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Xiaopin Duan

42 papers receiving 5.0k citations

Hit Papers

Nanoparticle‐Mediated Immunogenic Cell Death Enab... 2012 2026 2016 2021 2018 2012 2016 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaopin Duan China 24 3.1k 1.5k 1.3k 1.3k 1.1k 44 5.0k
Weijing Yang China 37 2.5k 0.8× 1.3k 0.9× 1.4k 1.1× 995 0.8× 792 0.7× 69 4.1k
Kaiyuan Ni United States 38 4.8k 1.5× 1.3k 0.9× 1.3k 1.0× 2.9k 2.2× 1.2k 1.1× 56 7.0k
Mingbin Zheng China 37 5.4k 1.7× 2.2k 1.5× 1.9k 1.4× 1.8k 1.4× 629 0.6× 77 6.8k
Chu‐Xin Li China 33 4.8k 1.5× 1.4k 0.9× 1.5k 1.1× 2.4k 1.9× 727 0.6× 52 6.0k
Ming Wu China 40 2.8k 0.9× 1.2k 0.8× 1.6k 1.2× 1.3k 1.0× 450 0.4× 103 4.9k
Wenlong Liu China 19 3.0k 0.9× 990 0.6× 1.1k 0.8× 1.3k 1.0× 591 0.5× 33 3.8k
Nining Guo United States 16 2.7k 0.9× 684 0.4× 634 0.5× 1.1k 0.9× 972 0.9× 20 3.6k
Yiye Li China 30 2.3k 0.7× 1.3k 0.8× 1.4k 1.1× 1.6k 1.2× 455 0.4× 50 4.3k
Yuanzeng Min China 28 2.0k 0.6× 1.5k 1.0× 1.3k 1.0× 1.1k 0.8× 588 0.5× 61 4.0k
Fuwu Zhang United States 44 3.4k 1.1× 2.6k 1.7× 2.1k 1.6× 1.9k 1.5× 979 0.9× 94 6.7k

Countries citing papers authored by Xiaopin Duan

Since Specialization
Citations

This map shows the geographic impact of Xiaopin Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopin Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopin Duan more than expected).

Fields of papers citing papers by Xiaopin Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopin Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopin Duan. The network helps show where Xiaopin Duan may publish in the future.

Co-authorship network of co-authors of Xiaopin Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaopin Duan. A scholar is included among the top collaborators of Xiaopin Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaopin Duan. Xiaopin Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
4.
Wang, Zhenyu, et al.. (2024). pH and ROS Dual‐Responsive Autocatalytic Release System Potentiates Immunotherapy of Colorectal Cancer. Advanced Healthcare Materials. 13(29). e2401126–e2401126. 5 indexed citations
5.
Li, Jiaxin, Qilin Yu, Peishan Li, et al.. (2024). Laser-activable murine ferritin nanocage for chemo-photothermal therapy of colorectal cancer. Journal of Nanobiotechnology. 22(1). 297–297. 7 indexed citations
6.
Li, Jiaxin, Yanqun Zhang, Hongxin Huang, et al.. (2024). Short cell-penetration peptide conjugated bioreducible polymer enhances gene editing of CRISPR system. Journal of Nanobiotechnology. 22(1). 284–284. 5 indexed citations
7.
Yang, Jing, Wei Xiong, Lin Huang, et al.. (2024). A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumor ferroptosis therapy. Journal of Nanobiotechnology. 22(1). 204–204. 16 indexed citations
8.
Li, Peishan, et al.. (2024). Hypoxia-responsive liposome enhances intracellular delivery of photosensitizer for effective photodynamic therapy. Journal of Controlled Release. 377. 277–287. 9 indexed citations
9.
Yang, Jing, Jie Feng, Xiaopin Duan, et al.. (2024). Hollow mesoporous calcium peroxide nanoparticles for drug-free tumor calcicoptosis therapy. Acta Biomaterialia. 185. 456–466. 6 indexed citations
10.
Zhu, Junqiao, Xiaobin Huang, Tingting You, et al.. (2023). Hypoxia‐Responsive Nanoscale Coordination Polymer Enhances the Crosstalk Between Ferroptosis and Immunotherapy. Advanced Functional Materials. 33(35). 12 indexed citations
11.
Zhu, Junqiao, et al.. (2022). CD47-SIRPα axis in cancer therapy: Precise delivery of CD47-targeted therapeutics and design of anti-phagocytic drug delivery systems. SHILAP Revista de lepidopterología. 15. 100139–100139. 7 indexed citations
12.
Xiao, Jisheng, Haishan Li, Tingting You, et al.. (2022). Zinc-metal–organic frameworks with tunable UV diffuse-reflectance as sunscreens. Journal of Nanobiotechnology. 20(1). 87–87. 20 indexed citations
13.
Han, Wenbo, Xiaopin Duan, Kaiyuan Ni, et al.. (2021). Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy. Biomaterials. 280. 121315–121315. 85 indexed citations
14.
Duan, Xiaopin, Christina Chan, Wenbo Han, et al.. (2019). Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors. Nature Communications. 10(1). 1899–1899. 222 indexed citations
15.
Chan, Christina, Nining Guo, Xiaopin Duan, et al.. (2019). Systemic miRNA delivery by nontoxic nanoscale coordination polymers limits epithelial-to-mesenchymal transition and suppresses liver metastases of colorectal cancer. Biomaterials. 210. 94–104. 27 indexed citations
16.
He, Chunbai, Xiaopin Duan, Nining Guo, et al.. (2016). Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nature Communications. 7(1). 12499–12499. 668 indexed citations breakdown →
17.
Duan, Xiaopin, Jisheng Xiao, Qi Yin, et al.. (2014). Multi-targeted inhibition of tumor growth and lung metastasis by redox-sensitive shell crosslinked micelles loading disulfiram. Nanotechnology. 25(12). 125102–125102. 42 indexed citations
18.
Wang, Linlin, Liang Li, Yujiao Sun, et al.. (2014). In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin. International Journal of Pharmaceutics. 471(1-2). 391–399. 33 indexed citations
19.
Xiao, Jisheng, Xiaopin Duan, Qingshuo Meng, et al.. (2014). Effective delivery of p65 shRNA by optimized Tween 85-polyethyleneimine conjugate for inhibition of tumor growth and lymphatic metastasis. Acta Biomaterialia. 10(6). 2674–2683. 15 indexed citations
20.
Duan, Xiaopin & Shirui Mao. (2010). New strategies to improve the intranasal absorption of insulin. Drug Discovery Today. 15(11-12). 416–427. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026